LATEST UPDATES » Vol 24, No. 10, October 2020 – Artificial Intelligence Technologies — Helping the Fight Against COVID-19s       » Improving Sensitivity of Optical Receivers for Space Communication       » Genetic Variants Identified for the Susceptibility to Neuroblastoma       » Novo Nordisk Launches New Treatment for Diabetes in Singapore       » SMART Researchers Find New Way to Make Bacteria More Sensitive to Antibiotics       » Study Finds Liver Injury to be Common Among COVID-19 Patients      
Vol 24, No. 03, March 2020   |   Issue PDF view/purchase
Gaming Technology for Elder Care

Supporting the ageing population through innovative technologies.

Taiwanese HealthTech start-up, LongGood Meditech first entered the Singapore market in 2016. Aspiring to support the ageing community in the region, LongGood aims to empower over 120,000 people by 2022 with gamified rehabilitation programmes equipped with motion-sensing technology. As a step towards this goal, in 2019, LongGood’s PAPAMAMA system has been adopted by 37 healthcare and medical facilities across Singapore with over 1,500 patients benefitting from it. Giving us more in-depth overview of LongGood’s PAPAMAMA system and how it will benefit the ageing population is Ms Zoe Liang, Chief Operating Officer, LongGood Meditech.

1. What are the key features of LongGood’s PAPAMAMA system and how these will change the game for elder care in Singapore?

LongGood’s PAPAMAMA system combines the use of motion-sensing technology with virtual reality to detect multiple points on the patient’s body and project a motion-activated image onto a TV or projection screen. The system then guides patients to execute various professionally designed rehabilitation trainings that are repackaged into a series of games. Through gamification, patient rehabilitation is enhanced by ensuring that patients receive the care they need in a fun and interactive way while socialising with their loved ones.

Another key benefit of the PAPAMAMA system is that it can easily be installed in the comfort of patients’ homes due to its portability and easy-to-operate interface. This greatly reduces the need for patients to make frequent commutes to and from hospitals, which may be particularly difficult for seniors. Additionally, the PAPAMAMA system’s cloud capabilities allow therapists to remotely monitor their patients and evaluate their progress, which helps to maximise healthcare resources and meet the demand for trained therapists in Singapore.

2. Why did LongGood Meditech chose Singapore as its first stop for this expansion into Southeast Asia?

As with many Asian countries, Singapore is no stranger to the problems of an ageing population. Over the last decade, Singapore’s population has grown older with an increasing number of seniors and fewer younger people as life expectancy increases and birth rate declines. In fact, the proportion of residents aged above 65 years has risen by 5.6 percent over the last 10 years. We see this as an opportunity to help meaningfully improve the lives of Singapore’s seniors through our solution.

We’re also thankful to have received the DBS Foundation grant in 2016, which supported our development and marketing efforts for expanding into Singapore. It’s generally challenging for small start-ups like ours to break into new markets, but DBS opened doors for us to business opportunities in Singapore, showed us the ropes of doing business here, and helped to build our network of industry partners and distributors.

3. How is the system implemented in Singapore?

Our PAPAMAMA solution is presently adopted by two rehabilitation centres in Singapore. We are also in talks with major local hospitals and healthcare centres about implementing the system to provide free trials at their facilities, for patients who have undergone medical illnesses that resulted in physical disability or difficulties.

4. Are there currently any collaborations with healthcare policies?

We have not collaborated specifically on healthcare policies yet but are exploring other interesting collaborations that will allow us to create positive impact through varying ways.

One such example is a partnership with real estate developers in Taiwan. They approached us as they wanted to provide our solution as part of the residential facilities, so that seniors could have access to rehabilitation services whenever they want, and without having to travel long distances.

5. Will there be any form of data collection for elderly patients using the system? If so, will the data be used to make future improvements on the system?

Currently, physiotherapists evaluate patients mostly through observation, as well as institutional and professional knowledge. We’re exploring how to use artificial intelligence (AI) technology to build a disease evaluation tool where different neuro-skeletal models can be mapped and used to identify physiological or gait abnormalities of the patient. With this AI tool, we seek to gain certainty in patient diagnosis and evaluation by further sharpening and refining the process.

6. Their strategy and future plans for the business – how to balance profitability and social good

LongGood (and our PAPAMAMA tele-rehabilitation system) was conceptualised and founded with the desire to improve quality of life for patients suffering from musculoskeletal problems by democratising access to quality physical rehabilitation programmes.

We’re proud to share that the PAPAMAMA system has benefitted over 1,500 patients in Taiwan since our launch in 2011, and it is our aim to positively impact even more lives by empowering them in their rehabilitation efforts. We see ample potential beyond our shores – particularly in Asia, which is home to some of the most rapidly ageing populations in the world – and our goal is to extend our tele-rehabilitation programme to 120,000 people by 2022, starting with Singapore, Greater China, Hong Kong and Macau.

About the Interviewee

Ms Zoe Liang, Chief Operating Officer, LongGood Meditech

news PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season
news PharmaSources.com to Help Propel the Chinese API Export Business with E-Trade Session CPhI China Top API Exporters & Products
news Singapore Biomedical Company Appointed as a Certified Service Provider by 10x Genomics
news Proteona Honoured with "one to watch" Prize in the Inaugural Spinoff Prize by Nature Research and Merck Grou

About Us
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2020 World Scientific Publishing Co Pte Ltd  •  Privacy Policy